New Maternal Vaccine Safety Surveillance Program Launches
The three-year initiative improves vaccine safety monitoring for expectant individuals in Kenya and Ghana.
Updated on Oct. 23, 2026 in Pregnancy
Live Poll
Do you trust that better data monitoring for maternal vaccines increases overall vaccine safety?
The Kenya Medical Research Institute (KEMRI) and global partners are launching the second phase of a three-year maternal vaccine safety program. This initiative aims to strengthen how pregnancy and newborn health outcomes are tracked across healthcare systems in Kenya and Ghana.
Why it matters
Active safety surveillance provides long-term data on vaccine impact, helping regulators make informed decisions about maternal health. Integrating these systems into clinical workflows ensures better data collection without overburdening healthcare providers.
The program is structured as a three-year implementation phase spanning Kenya and Ghana that links pregnancy databases with existing health records. The long-term efficacy of these integrated surveillance systems for informing regulatory safety decisions is currently under evaluation.
The players
KEMRI
The Kenya Medical Research Institute is a state-run health research body that focuses on human health, medical diagnostics, and vaccine safety.
African Medicines Agency
A continental health body that coordinates regulatory oversight and vaccine safety monitoring across African nations.
The details
The surveillance system works by linking pregnancy databases directly to electronic medical records, allowing researchers to observe health outcomes for both mothers and newborns. By embedding these processes into routine clinical practice, the program intends to capture data accurately without increasing workloads for health workers. Future pilot studies will explore how artificial intelligence can further automate these links within existing information systems.
Timeline
October 14-16, 2026: Partners met in Malindi to define priorities for Phase II.
Health Landscape
This effort is part of a broader continental shift toward standardized, data-driven vaccine monitoring systems overseen by the African Medicines Agency. It marks a transition from localized monitoring to integrated regional health surveillance for maternal and newborn care.
This program emphasizes the importance of tracking health outcomes to support vaccine safety for pregnant individuals and their children. Patients should feel comfortable discussing the latest safety data and immunization benefits during regular prenatal visits with their obstetrician.
The takeaway
Robust surveillance systems are essential for ensuring that maternal immunization remains safe and effective for patients and newborns. Always consult your primary care physician to understand the latest safety recommendations tailored to your personal health history.
Further reading
Learn more about advancements in Pregnancy care and safety monitoring.
Source note: This article includes information reported by KEMRI.
Live Poll
Do you trust that better data monitoring for maternal vaccines increases overall vaccine safety?
